Angiostatic, tumor inflammatory and anti-tumor effects of CXCL4(47-70) and CXCL4L1(47-70) in an EGF-dependent breast cancer model (original) (raw)
CXCL4 and CXCL4L1 in cancer
Pieter Ruytinx
Cytokine, 2018
View PDFchevron_right
The Chemokine CXCL16 and Its Receptor, CXCR6, as Markers and Promoters of Inflammation-Associated Cancers
Merav Darash-yahana
PLoS ONE, 2009
View PDFchevron_right
Expression of the inflammatory chemokines CCL2, CCL5 and CXCL2 and the receptors CCR1–3 and CXCR2 in T lymphocytes from mammary tumor-bearing mice
Michael Criscitiello, Marta Torroella-Kouri
Cellular Immunology, 2011
View PDFchevron_right
Multiple functions of CXCL12 in a syngeneic model of breast cancer
Mark Smyth
Molecular Cancer, 2010
View PDFchevron_right
Role of CXCL12 and CXCR4 in the pathogenesis of hematological malignancies
Michal Abraham
Cytokine, 2018
View PDFchevron_right
CXCL9, CXCL10, CXCL11/CXCR3 axis for immune activation - A target for novel cancer therapy
Shivani Soni
Cancer treatment reviews, 2018
View PDFchevron_right
Mini-review The role of CXC chemokines and their receptors in cancer
Itzel Camacho Blue
View PDFchevron_right
CXCL12 in Malignant Glial Tumors: A Possible Role in Angiogenesis and Cross-Talk between Endothelial and Tumoral Cells
Amerigo Boiardi
Journal of Neuro-Oncology, 2004
View PDFchevron_right
CXCR1 and CXCR2 Chemokine Receptor Agonists Produced by Tumors Induce Neutrophil Extracellular Traps that Interfere with Immune Cytotoxicity
Mario Mellado
Immunity, 2020
View PDFchevron_right
Scientific heading: Chemokines PF4/CXCL4 and CXCL4L1 exhibit distinct subcellular localization and a differentially regulated mechanism of secretion
laura lasagni
2007
View PDFchevron_right
Angiostatic and chemotactic activities of the CXC chemokine CXCL4L1 (platelet factor-4 variant) are mediated by CXCR3
craig gerard
Blood, 2010
View PDFchevron_right
Cyclooxygenase-2-Dependent Expression of Angiogenic CXC Chemokines ENA-78/CXC Ligand (CXCL) 5 and Interleukin-8/CXCL8 in Human Non-Small Cell Lung Cancer
Sherven Sharma
Cancer Research, 2004
View PDFchevron_right
Loss of new chemokine CXCL14 in tumor tissue is associated with low infiltration by dendritic cells (DC), while restoration of human CXCL14 expression in tumor cells causes attraction of DC both in vitro and in vivo
Anna Lokshin, Galina Shurin, Michael Shurin
The Journal of Immunology, 2006
View PDFchevron_right
Chemokine CXCL13 is overexpressed in the tumour tissue and in the peripheral blood of breast cancer patients
Tim Bartels
British Journal of Cancer, 2008
View PDFchevron_right
Loss of New Chemokine CXCL14 in Tumor Tissue Is Associated with Low Infiltration by Dendritic Cells (DC), while Restoration of Human CXCL14 Expression in Tumor Cells Causes Attraction of DC Both In Vitro and In Vivo1
Robert Ferris
View PDFchevron_right
Characterization of the Role of CXCL 10 and CXCR 3 in Breast Cancer
Nalan Gokgoz
2009
View PDFchevron_right
The CXCL12–CXCR4 Chemokine Pathway: A Novel Axis Regulates Lymphangiogenesis
Yongzhang Luo
Clinical Cancer Research, 2012
View PDFchevron_right
Interaction between neoplastic cells and cancer-associated fibroblasts through the CXCL12/CXCR4 axis: Role in non–small cell lung cancer tumor proliferation
Sophie Kirshberg
The Journal of Thoracic and Cardiovascular Surgery, 2011
View PDFchevron_right
CXC chemokines mechanism of action in regulating tumor angiogenesis
Peter Polverini
Angiogenesis, 1998
View PDFchevron_right
The Chemokine CXCL8 in Carcinogenesis and Drug Response
Temesgen Samuel
ISRN Oncology, 2013
View PDFchevron_right
Macrophages may promote cancer growth via a GM-CSF/HB-EGF paracrine loop that is enhanced by CXCL12
Massimiliano Bonifacio, Pierluigi Mauri, Alberto Zamo
Molecular Cancer, 2010
View PDFchevron_right
The prognostic value of lymph nodes mRNA CXCL12 expression in the breast cancer
Didik Heriyanto
Journal of thee Medical Sciences (Berkala Ilmu Kedokteran)
View PDFchevron_right
CXCR1/2 antagonism with CXCL8/Interleukin-8 analogue CXCL8(3-72)K11R/G31P restricts lung cancer growth by inhibiting tumor cell proliferation and suppressing angiogenesis
John R Gordon, PhD, FCAHS
Oncotarget, 2015
View PDFchevron_right
CXC and CC Chemokines as Angiogenic Modulators in Nonhaematological Tumors
Massimo Nabissi
BioMed Research International, 2014
View PDFchevron_right
The expression of the chemokine receptor CXCR3 and its ligand, CXCL10, in human breast adenocarcinoma cell lines
Eran Neumark
Immunology Letters, 2004
View PDFchevron_right
CXCL12/CXCR4 Blockade Induces Multimodal Antitumor Effects That Prolong Survival in an Immunocompetent Mouse Model of Ovarian Cancer
Pierre Leblanc
Cancer Research, 2011
View PDFchevron_right
CXCL4 and CXCL4L1 Differentially Affect Monocyte Survival and Dendritic Cell Differentiation and Phagocytosis
Pieter Ruytinx
PLOS ONE, 2016
View PDFchevron_right
Scavenging of CXCL12 by CXCR7 promotes tumor growth and metastasis of CXCR4-positive breast cancer cells
Dafydd THOMAS
Oncogene, 2012
View PDFchevron_right
The Role of CXC Chemokines in the Regulation of Angiogenesis in Association with Lung Cancer
Peter Polverini
Trends in Cardiovascular Medicine, 1998
View PDFchevron_right
fContribution of CXCL12 secretion to invasion of breast cancer cells
Salvatore Coniglio
Breast Cancer Research, 2012
View PDFchevron_right
Fatal attractions? Correlations of CXCL12-CXCR4-CXCR7 expression with disease progression in melanoma and Kaposi sarcoma
Lindsay Spender
British Journal of Dermatology, 2016
View PDFchevron_right
The role of CXC chemokines in the regulation of angiogenesis in non-small cell lung cancer
Peter Polverini
Journal of Leukocyte Biology, 1997
View PDFchevron_right
Targeting CXCL12/CXCR4 Axis in Tumor Immunotherapy
Mingli Liu
Current Medicinal Chemistry, 2019
View PDFchevron_right
Contribution of CXCL12 secretion to invasion of breast cancer cells
Salvatore Coniglio
Breast Cancer Research, 2012
View PDFchevron_right
CXCL16 positively correlated with M2-macrophage infiltration, enhanced angiogenesis, and poor prognosis in thyroid cancer
Young Shin Song
Scientific Reports, 2019
View PDFchevron_right